financetom
Business
financetom
/
Business
/
Abercrombie & Fitch Co's Fiscal Q3 Adjusted Earnings, Revenue Rise; Raises Fiscal 2024 Sales Guidance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Abercrombie & Fitch Co's Fiscal Q3 Adjusted Earnings, Revenue Rise; Raises Fiscal 2024 Sales Guidance
Nov 26, 2024 5:05 AM

07:50 AM EST, 11/26/2024 (MT Newswires) -- Abercrombie & Fitch Co ( ANF ) reported fiscal Q3 adjusted earnings Tuesday of $2.50 per diluted share, up from $1.90 a year earlier.

Analysts polled by FactSet expected $2.39.

Revenue for the quarter ended Nov. 2 was $1.21 billion compared with $1.06 billion a year earlier.

Analysts surveyed by FactSet expected $1.19 billion.

The company raised its fiscal 2024 net sales growth guidance to 14% to 15% compared with 12% to 13% previously expected. Analysts polled by FactSet expect $4.87 billion.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Bowflex Inc Says Co Files For Voluntary Chapter 11 Protection & Reaches Stalking Horse Agreement To Facilitate Sale
BRIEF-Bowflex Inc Says Co Files For Voluntary Chapter 11 Protection & Reaches Stalking Horse Agreement To Facilitate Sale
Mar 4, 2024
March 5 (Reuters) - BowFlex Inc ( BFX ): * BOWFLEX INC. ( BFX ) FILES FOR VOLUNTARY CHAPTER 11 PROTECTION AND REACHES STALKING HORSE AGREEMENT TO FACILITATE SALE * BOWFLEX ( BFX ) - SECURED COMMITMENT FOR $25 MILLION IN DIP FINANCING TO CONTINUE TO FULFILL CUSTOMER ORDERS AND SUPPORT ORDINARY COURSE OPERATIONS * BOWFLEX ( BFX ) :...
Tandem Diabetes Care Plans $250 Million Private Placement Notes -- Shares Decline After Hours
Tandem Diabetes Care Plans $250 Million Private Placement Notes -- Shares Decline After Hours
Mar 4, 2024
05:31 PM EST, 03/04/2024 (MT Newswires) -- Tandem Diabetes Care ( TNDM ) said Monday it plans a private placement of $250 million in principal amount of convertible notes due 2029. Initial purchasers will have the option to buy up to an additional $37.5 million principal amount of notes, according to the company. Net proceeds, along with cash at hand,...
PRESS DIGEST- Financial Times - March 5
PRESS DIGEST- Financial Times - March 5
Mar 4, 2024
March 5 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy. Headlines - Cinven agrees to buy majority stake in fund administrator Alter Domus - Jeremy Hunt set to give motorists 5 bln pound tax break in the Budget - 'Erroneous' filings highlight flaws...
BRIEF-Telix To Acquire ARTMS Inc And Its Advanced Isotope Production Platform
BRIEF-Telix To Acquire ARTMS Inc And Its Advanced Isotope Production Platform
Mar 4, 2024
March 4 (Reuters) - Telix Pharmaceuticals Ltd ( TLPPF ): * TELIX TO ACQUIRE ARTMS, INC. AND ITS ADVANCED ISOTOPE PRODUCTION PLATFORM * TELIX PHARMACEUTICALS LTD ( TLPPF ) - ACQUISITION HAS POTENTIAL TO BE FINANCIALLY ACCRETIVE, ADD ADDITIONAL REVENUE * TELIX PHARMACEUTICALS LTD ( TLPPF ) - ACQUISITION HAS POTENTIAL TO HAVE POSITIVE IMPACT ON GROSS MARGINS FOR ILLUCCIX...
Copyright 2023-2026 - www.financetom.com All Rights Reserved